Efficient synthesis and anti-enteroviral activity of 9-arylpurines

Leire Aguado, María-Dolores Canela, Hendrik Jan Thibaut, Eva-María Priego, María-José Camarasa, Pieter Leyssen, Johan Neyts, María-Jesús Pérez-Pérez

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    To further explore the anti-enteroviral activity of 9-aryl-6-chloropurines, three different series of compounds with a dialkylamino, (alkyl)amido, or oxazolidinone substituent at the aryl ring have been synthesized, in most cases with the aid of microwave-assisted synthesis. The resulting compounds efficiently inhibit Coxsackie virus type B3 (CVB3) replication with EC(50) values varying from 3 to 15 μM, and with no significant toxicity in Vero cells. The most potent compounds also selectively inhibit the replication of other enteroviruses including Coxsackie virus B4 and Echo virus 11. The cross-resistance studies performed with different 9-aryl-6-chloropurines indicate that they all belong to the same pharmacological family and differ from other CVB3 drugs such as enviroxime.

    Original languageEnglish
    Pages (from-to)279-88
    Number of pages10
    JournalEuropean Journal of Medicinal Chemistry
    Volume49
    DOIs
    Publication statusPublished - 2012

    Keywords

    • Animals
    • Antiviral Agents
    • Cell Line
    • Cercopithecus aethiops
    • Enterovirus B, Human
    • Enterovirus Infections
    • Halogenation
    • Humans
    • Microbial Sensitivity Tests
    • Microwaves
    • Models, Molecular
    • Oxazolidinones
    • Purines
    • Vero Cells

    Fingerprint

    Dive into the research topics of 'Efficient synthesis and anti-enteroviral activity of 9-arylpurines'. Together they form a unique fingerprint.

    Cite this